The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Previous

Food Coma's Impact on Those Battling Hepatitis C

Back to News Homepage

Next

Triple Drug Cocktail Can Defeat Hepatitis C with Cirrhosis

Hemopurifier® to Aid Hep C Therapy in Compassionate-Use Program

Print this page

A first-in-class medical device that helps clear Hepatitis C from the blood, the Hemopurifier® will be part of a compassionate-use program for previous Hepatitis C non-responders or relapsers in India.

Aethlon Medical Announces Initiation Of Compassionate-Use Program To Treat Hepatitis C Virus (HCV)

SAN DIEGO, Dec. 3, 2012 /PRNewswire/ – Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, today announced the initiation of a compassionate-use clinical program to treat individuals infected with Hepatitis C virus (HCV). The compassionate-use program, which has been approved by the Institutional Review Board at the Medanta Medicity Institute (Medicity), will provide individuals who previously failed or subsequently relapsed standard-of-care drug regimens with treatment access to the Aethlon Hemopurifier®. The Hemopurifier® is a first-in-class medical device that selectively targets the rapid clearance of HCV from the entire circulatory system to improve benefit, dosing, duration and tolerability of drug therapies.

Continue reading this entire article:
http://www.prnewswire.com/news-releases/aethlon-medical-announces-initiation-of-compassionate-use-program-to-treat-hepatitis-c-virus-hcv-181810611.html

3 Comments
Share
Share

Previous

Food Coma's Impact on Those Battling Hepatitis C

Back to News Homepage

Next

Triple Drug Cocktail Can Defeat Hepatitis C with Cirrhosis

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.